Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2026 Nov 2.
Published in final edited form as: Pharmacol Biochem Behav. 2023 Apr 29;225:173557. doi: 10.1016/j.pbb.2023.173557

Emotion-related impulsivity moderates the role of arousal on reflection impulsivity

Aleksandra M Herman a,b,*, Matthew V Elliott c, Sheri L Johnson c
PMCID: PMC13723948  NIHMSID: NIHMS2218248  PMID: 37127224

Abstract

Emotion-related impulsivity is an important behavioural phenotype in clinical psychology and public health. Here, we test the hypothesis that emotion-related impulsivity moderates the effects of arousal on cognition using pharmacological manipulation. Participants completed a measure of emotion-related impulsivity, four cognitive tasks tapping onto different facets of impulsive behaviours, and a blinded arousal manipulation using yohimbine hydrochloride, which acts on noradrenergic receptors. Our findings suggest that emotion-related impulsivity moderates the role of arousal on impulsive performance on the Information Sampling Task. As expected, more severe emotion-related impulsivity was related to more impulsive decisions in the yohimbine but not in the placebo group. Results provide some of the first experimental evidence that emotion-related impulsivity is related to differential behavioural responses in the face of high arousal. Despite this preliminary support, we discuss findings for one task that did not fit hypotheses, and provide suggestions for replication and extension.

Keywords: Arousal; Emotion-related impulsivity; Yohimbine hydrochloride, information sampling task; Stop signal task; Urgency; Reflection impulsivity; UPPS-P

1. Introduction

It is increasingly well-recognized that impulsivity is an umbrella term, with multiple dimensions that are only modestly correlated (Whiteside and Lynam, 2001; Caswell et al., 2015). One form of self-reported impulsivity, emotion-related impulsivity, is defined by the tendency toward rash and regrettable responses to states of high emotion (Cyders and Smith, 2008). It is most commonly assessed using the Negative Urgency and Positive Urgency scales, which capture responses to negative and positive emotions, respectively (Whiteside and Lynam, 2001; Cyders et al., 2007). A growing body of large-scale research suggests that Negative and Positive Urgency scales are so closely correlated that they form a higher-order factor, and they show commonalities in network analyses as well (Billieux et al., 2021; Sperry et al., 2018). Given that the phenomenon appears non-specific to valence, we refer to this as emotion-related impulsivity.

Emotion-related impulsivity is an important behavioural phenotype in clinical psychology and public health. It has shown robust correlations with psychopathology across multiple meta-analyses, including depression, substance use, eating disorders, aggression, and suicidality (Berg et al., 2015; Beach et al., 2021). The observed effects are consistently higher than those observed for other forms of self-rated impulsivity (Berg et al., 2015), and as robust as effects for other major psychopathology risk factors, such as neuroticism (Malouff et al., 2005).

Emotion-related impulsivity has been well-validated as predicting symptomatic behaviour after mood inductions, including more drinking, more dietary lapses, and more risky behaviour (VanderVeen et al., 2016; Cyders and Smith, 2008; Cyders et al., 2010; Fischer et al., 2008; Manasse et al., 2018). Intriguingly, most studies using standardised mood inductions do not suggest that emotion-related impulsivity is tied to a larger subjective or physiological emotion response (Johnson et al., 2017; Owens et al., 2018; Wise et al., 2015). Rather, current conceptual models focus on the idea that cognitive processes may differentially decay during these states of high emotion, leading to increases in symptomatic behaviour, for those with higher emotion-related impulsivity (Carver et al., 2017). The current study, then, focuses on two parts of this model: documenting the responsivity to emotional arousal, and considering the nature of neurocognitive processes that are disrupted.

As the effects of emotion-related impulsivity on symptoms have been well-documented after both positive and negative mood inductions, some have argued that the critical trigger may be a differential response to states of high arousal, regardless of valence (Pearlstein et al., 2019). Work by Mather has identified specific neurobiological mechanisms through which norepinephrine, which is tightly correlated with subjective arousal ratings, is key to tuning neural regions to support effective cognitive processing during states of high arousal (Mather et al., 2016). Our working model is that arousal-related processes related to norepinephrine may be disrupted for those with higher emotion-related impulsivity. In one dynamic test of the idea that arousal is central to this effect, researchers used pupil dilation, which is innervated by norepinephrine, to show that those with higher emotion-related impulsivity showed differential cognitive performance with subtle increases in arousal across trials of a cognitive task (the antisaccade task) (Pearlstein et al., 2019). Increases in arousal in this study benefited cognitive performance on the antisaccade task for those with relatively lower emotion-related impulsivity. In contrast, participants with higher emotion-related impulsivity showed decrements in performance on the higher arousal trials. These effects were observed even though emotion-related impulsivity was unrelated to the degree of arousal. While intriguing, these findings were limited by the lack of experimental control over arousal levels, and the very limited variation in arousal across task trials—which likely are much subtler than the types of arousal shifts that would occur when facing real-life stressors and challenges.

Here, then, we extend the work on emotion-related impulsivity as a moderator of the effects of arousal on cognition by using a dataset from a published study employing placebo-controlled pharmacological manipulation of arousal through experimental manipulation of yohimbine hydrochloride (Herman et al., 2019a). Yohimbine is an alpha-2 adrenergic receptor antagonist that increases norepinephrine release and physiological arousal.

Past research has implicated response inhibition (motor impulsivity) and information sampling under uncertainty (reflection impulsivity) as potential cognitive correlates of emotion-related impulsivity in patient populations (Pearlstein et al., 2022; Franken et al., 2008; Canale et al., 2022; Johnson et al., 2016). Recent studies also suggest that those with higher emotion-related impulsivity show problems of response inhibition specifically when arousal cues are present (Roxburgh et al., 2022; Allen and Hooley, 2019). Therefore, we hypothesised that effects would emerge in tasks from those cognitive domains only during yohimbine administration. The available dataset also included data from delay and probability discounting measures. We analysed these as control comparisons, as these were based on self-report questionnaires and we did not have specific hypotheses about them. This additional comparison allowed us to test whether emotion-related impulsivity would show a specific profile of arousal-related effects on impulsive behaviour.

We also tested the specificity of self-rated forms of impulsivity. Emotion-related impulsivity items are unique in their content, which focus on tendencies to engage in rash and regrettable behaviour specifically during states of emotional arousal. As a comparison, we considered the three other subscales of the UPPS-P impulsive behaviour scale (namely Premeditation, Perseverance and Sensation-Seeking; Cyders and Smith, 2008; Whiteside and Lynam, 2001). As items on these subscales do not reference arousal levels, we hypothesised that these three other self-rated forms of impulsivity would not be related to amplified impulsive behaviours after yohimbine administration.

In sum, we hypothesised that emotion-related impulsivity would moderate the relationship between yohimbine administration and laboratory task performance, such that more severe emotion-related impulsivity would relate to increased impulsive behaviour in the yohimbine group, but not in the placebo group. Moreover, we expected effects to be specific to response inhibition and information gathering of the four behavioural measures and to be specific to emotion-related impulsivity out of the four self-rated impulsivity subscales. We expected null effects expected for the remaining subscales.

2. Methods

Data were drawn from a parent study, which examined the effects of yohimbine administration on laboratory measures of impulsivity (Herman et al., 2019a). The original publication of this dataset demonstrated that yohimbine administration caused more far-sighted decisions in the Delay Discounting Task (lower temporal impulsivity) yet reduced information gathering in the Information Sampling Task (increased reflection impulsivity). The original publication, though, did not consider potential moderation by emotion-related impulsivity; details of the study procedures were described there (Herman et al., 2019a). Briefly, participants completed interview measures to exclude those with recreational drug use, or with a history or current psychiatric, neurological, or major medical disorder. 42 participants (21 per group; 23 females; aged 22.24 ± 4.52 years old, range: 18–40) met inclusion criteria and completed the UPPS-P Questionnaire (Whiteside and Lynam, 2001; Cyders et al., 2007; Lynam et al., 2006), which provides scores for five dimensions of trait impulsivity. For the purpose of the present study, we created the Emotion-related impulsivity variable as the composite of the UPPS-P Positive and Negative Urgency subscales (the two subscales showed a high correlation coefficient, r = 0.84) by averaging the scores for each subject.

Participants received a single dose of either 20 mg of yohimbine hydrochloride or placebo. After drug ingestion (75 min ± 30 min), participants completed the four behavioural impulsivity measures in randomised order.

As reported in the original publication, several tests were conducted to assess the success of randomization and pharmacological manipulation. Participants in the yohimbine vs. placebo groups were matched on a measure of working memory (Rey Auditory Verbal Learning Test; Rey, 1964), as well as age, height, BMI, and mood state before the manipulation. Participants also completed post-study questionnaires, which confirmed that participants were not able to accurately assess whether they had received the active or placebo drug.

Blood pressure and subjective arousal were monitored in both groups, to confirm the drug manipulation. As previously reported, the analysis of blood pressure changes revealed a trend for the expected time-group interaction (F(5, 200) = 1.90, p = .096, ηp2p = 0.045), and a significant main effect of time (F(5, 200) = 4.81, p < .001, ηp2p = 0.107). Planned post hoc tests revealed the expected profile in which the placebo group did not show significant changes in systolic blood pressure over time (F(5, 100) = 1.18, p = .326), the yohimbine group did show significant changes over time (F(5, 100) = 4.10, p = .002). No group differences in self-perceived arousal by condition, as measured using the 24-item Perceived Arousal Scale (Anderson et al., 1995), were found. The Information Sampling Task (IST; Clark et al., 2006) is a measure of reflection impulsivity. Participants sequentially open a grid of 25 boxes to reveal two colours underneath before selecting the colour in the majority. There are two conditions in the IST: the Fixed Win condition, in which the win depends solely on response accuracy (i.e., selecting the correct colour), and the Reward Conflict condition which introduces a trade-off between the reward and information gathering whereby the potential reward decreases proportionally to information sampled. Thus, unlike the Fixed Win condition, in which the optimal strategy is to sample information up to a point of complete certainty (which frequently means uncovering the whole matrix), in the Reward Conflict condition information gathering is costly and sampling information up to a point for certainty would lead to no gain at all. Therefore, we expected to see the moderating role of emotion-related impulsivity only in the Reward Conflict condition, which is likely to show higher inter-individual differences in performance. The dependent variable for both conditions is the probability of being correct that the participant tolerates at the point of decision-making [P(correct)].

The Affective Stop Signal Task (ASST; Herman et al., 2019b) is a measure of motor ‘stopping’ impulsivity (response inhibition) in an affective context. Participants respond to the gender of the person presented in the photo withholding this response whenever the frame surrounding the photo turns red (the Stop Signal that occurs in 25 % of trials). Images present neutral and fearful facial expressions. The task gives a measure of Stop Signal Reaction Time (SSRT), calculated separately for the neutral and fearful affective conditions.

The Probability Discounting (PD) task (Madden et al., 2009) is an index of risk-taking. Participants make a series of hypothetical choices between a small reward available for sure and a larger, uncertain amount. The task gives a measure of discounting of probabilistic rewards (h). Finally, the Monetary Choice Questionnaire (MCQ; Kirby et al., 1999) is a measure of temporal impulsivity. Here participants make a series of hypothetical choices between a small reward available immediately and a larger amount available after a delay. The task gives a measure of discounting of delayed rewards (k).

For the main analysis, to examine the hypothesis that emotion-related impulsivity would moderate the effects of yohimbine on performance on the impulsivity tasks, we used a linear regression model with interaction (drug x ERI). Five sets of analysis (5 models) were conducted to test for the moderation effect: for each IST condition (Fixed Win and Reward Conflict) separately, ASST, PD and MCQ. Of these, our main hypotheses focus on the IST Reward Conflict and the ASST. Continuous predictors were mean-centred and categorical variables were treated as factors. As there were two within-subject conditions in the ASST (neutral and fearful context), for the performance on that task, we used a three-way interaction (condition x drug x ERI) with mixed-linear models (Bates et al., 2015). As control analyses, we conducted parallel analyses with the remaining factors of the UPPS-P (namely Premeditation, Perseverance and Sensation-Seeking; 15 models). Analysis was performed in RStudio (version 1.3.1093). Data, code, and full HTML report are available on OSF (https://osf.io/zx9p7/?view_only=481c531076bb42339e6aefb573f3ba1b).

3. Results

Contrary to hypotheses, we did not see evidence that ERI moderated the effects of drugs on the ASST. Regarding the second main analysis of interest, ERI moderated the effects of a drug on impulsive behaviours only on the IST, and as hypothesised, this effect was specific to the Reward Conflict (β = −0.07, t = 2.53, p = .016; Fig. 1, Table 1) but not the Fixed Win condition. As hypothesised, the interaction of ERI by drug condition accounted for a significant proportion of the variance in information sampling [P(correct)], ΔF(1, 38) = 6.40, p = .016, over a model with main effects only. The overall moderation model with interaction explained approximately 15 % of the variance (R2 = 0.15), which is considered to be an adequate (Falk and Miller, 1992), moderately large effect size (Cohen, 1988).

Fig. 1.

Fig. 1.

Emotion-related impulsivity (ERI) by drug (Placebo vs Yohimbine) interaction predicting the performance in the Information Sampling Task, Reward Conflict condition.

Table 1.

Main effects and interaction models of Emotion-related impulsivity (ERI) by drug (Placebo vs Yohimbine) interaction predicting the performance in the Information Sampling Task, Reward Conflict condition. Significant effects (p < .05) are depicted in bold.

 
Main Effects Model
Interaction Model
Predictors β CI t p β CI t p
(Intercept) 0.73 0.69–0.77 40.12 <0.001 0.72 0.69–0.76 42.09 <0.001
ERI 0.00 −0.02–0.03 0.19 0.849 0.02 −0.01–0.06 1.62 0.113
Drug [Yohimbine] −0.01 −0.07–0.04 −0.52 0.605 −0.02 −0.07–0.03 −0.79 0.434
ERI × Drug [Yohimbine] −0.07 −0.12 to −0.01 −2.53 0.016
Observations 42 42
R2 / R2 adjusted 0.010 / −0.041 0.152 / 0.086

Control analyses with the three remaining UPPS-P subscales for each of the behavioural variables documented that the moderation of arousal was specific to ERI. That is, 14 out of the 15 effects were insignificant. Unexpectedly, there was a Sensation Seeking x drug interaction on response inhibition in the ASST (Parameter estimate = 42.18, t = 2.09, p = .041), whereby higher Sensation Seeking was associated with more inhibitory control in the placebo group (Table 2). In contrast, Sensation Seeking was not related to inhibitory control in the high arousal (Yohimbine) condition. There was no statistically significant three-way interaction with the SST condition (Neutral vs Fearful context). The overall moderation model for ASST with interaction with Sensation Seeking explained approximately 21 % of the variance (R2 = 0.21), which is considered to be an adequate (Falk and Miller, 1992), moderate effect size (Cohen, 1988).

Table 2.

Main effects and interaction models of Sensation Seeking with drug (Placebo vs Yohimbine) by emotion condition interaction predicting the performance in the Affective Stop Signal Task. Significant effects (p < .05) are depicted in bold. SSRTF - stop signal reaction time in Fearful emotion condition, P_ID - participant ID.

 
Sensation Seeking
Interaction
Predictors Estimates CI p Estimates CI p
(Intercept) 298.60 273.38–323.81 <0.001 313.85 286.78–340.92 <0.001
Emotion [SSRTF] 20.47 −4.19–45.12 0.101 17.04 −12.48–46.57 0.249
Drug [Yohimbine] −23.95 −61.41–13.52 0.205 −35.99 −72.94–0.95 0.056
Sensation Seeking −11.91 −29.02–5.21 0.167 −47.38 −81.22 to −13.53 0.007
Emotion [SSRTF] × Drug [Yohimbine] −20.91 −55.77–13.96 0.232 −11.08 −51.37–29.22 0.580
Emotion [SSRTF] × Sensation Seeking 7.96 −28.96–44.87 0.664
Drug [Yohimbine] × Sensation Seeking 42.18 1.76–82.60 0.041
(Emotion [SSRTF] × Drug [Yohimbine]) × Sensation Seeking 5.45 −38.64–49.53 0.803
Random Effects
σ2 1403.93 1424.92
τ00 1352.76 P_ID 1043.56 P_ID
ICC 0.49 0.42
N 38 P_ID 38 P_ID
Observations 76 76
Marginal R2 / Conditional R2 0.099 / 0.541 0.210 / 0.544

4. Discussion

In line with our hypothesis, the findings suggest that self-reported emotional impulsivity moderated the effect of group, such that ERI related to increased reflection impulsivity in the yohimbine group as compared to the placebo group. Specifically, those who reported greater self-reported emotion-related impulsivity showed higher reflection impulsivity (gathered less information) in the IST after yohimbine ingestion as compared to placebo. As expected, such a relationship was observed only in the Reward Conflict condition, in which sampling information to the point of certainty would result in no gain at all. Therefore, this condition introduces uncertainty at the point of decision-making compared to the Fixed Win condition (Clark et al., 2006). Accordingly, these results provide initial evidence for the idea that for individuals endorsing high self-reported emotion-related impulsivity, states of high arousal are related to more impulsive behaviours on one task.

Caution is warranted, however, as we also predicted an effect for response inhibition, given previous interactions of emotion-related impulsivity and arousal in predicting antisaccade performance (Pearlstein et al., 2019, 2022). It is important to note, though, that in the current study, those with a history of psychiatric illness were excluded from participation; the null results for the ASST and emotion-related impulsivity are consistent with a cross-study profile of overall lack of correlation of emotion-related impulsivity with response inhibition measures in nonclinical samples (Johnson et al., 2016).

Consistent with the multifaceted nature of behavioural measures of impulsivity (Herman et al., 2018; Caswell et al., 2015), we observed null results as expected for two control comparison behavioural indices. This fits with expectations that the cognitive processes involved in emotion-related impulsivity may be fairly specific and narrow.

Turning to the other forms of self-rated impulsivity, we predicted that deleterious effects of the arousal manipulation on behavioural performance would not be observed for the three other forms of self-rated impulsivity. Consistent with this idea, 14 of the 15 effects tested for other forms of impulsivity were null, and no other form of impulsivity predicted behavioural performance during the yohimbine condition. Unexpectedly, we found an interaction of arousal x Sensation Seeking on response inhibition (ASST). Since both, sensation seeking and response inhibition, have been linked to dopaminergic function (Norbury et al., 2013; Robertson et al., 2015), possibly, these unexpected findings are related to the fact that yohimbine, besides its effects on noradrenergic transmission, also promotes dopamine release in the brain (Brannan et al., 1991). Although the effect size obtained for the interaction model of interest was adequate and moderately large (R2 > 0.13; Falk and Miller, 1992; Cohen, 1988), further work is required to assess whether the effect we observed here is spurious, given the large number of tests conducted.

While the overall profile of findings is consistent with the idea that Emotion-related impulsivity might predict information gathering during the high arousal condition, caution is warranted for interpreting these effects given the limited sample size. Using G*Power (Faul et al., 2009), we tested whether adding 1 predictor (ERI x yohimbine interaction) would yield a significant change in R2 to a multiple regression model with 3 total predictors and 42 participants. The sensitivity power analysis found that with alpha = 0.05, we would have 80 % power to detect a change in R2 = 0.197. Our observed change in R2 for the IST model with the interaction was 0.142, suggesting that the analysis is underpowered. Given the small sample size, the null effect on one of the two expected behavioural impulsivity measures, these findings should be treated as preliminary and awaiting replication with a larger sample.

Notwithstanding the need for replication, these findings provide the first preliminary evidence that pharmacological manipulations can influence behavioural indicators of impulsivity differentially for those with higher vs. lower emotion-related impulsivity. These findings lend some insight into a profile of findings suggesting greater symptomatic behaviour for those with higher emotion-related impulsivity in laboratory studies after emotion induction procedures (Manasse et al., 2018; VanderVeen et al., 2016; Cyders et al., 2010). They also suggest one specific cognitive mechanism for more detailed study in future research on emotion-related impulsivity, as results were specific to reflection impulsivity. Intriguingly, in one measure of emotion-related impulsivity, researchers found that the standard items from the UPPS scale formed a broader factor that encompassed items capturing a tendency not to engage in reflection during states of high emotion (Carver et al., 2011). Conceptually, Cyders and Smith (Cyders and Smith, 2008) have argued that those with emotion-related impulsivity may experience an attentional focus on their emotional experience that would interfere with a focus on broader, longer-term goals (and the related reflection on how to sustain those goals). Taken together, theory, as well as evidence from behavioural and self-report research, then, suggest that lack of reflectiveness could be one process which shifts during states of heightened arousal for those with high emotion-related impulsivity - potentially increasing the risk of engaging in symptomatic behaviours.

If replicated, the greater specificity concerning the nature of arousal and the nature of cognition in relation to emotion-related impulsivity provides potential for basic psychopathology research as well as treatment development. More specifically, by identifying a behavioural process that might be disrupted by arousal, current findings could open the door for more careful laboratory and imaging research on sensitivity to arousal, and neurocognitive target processes. If such work confirms this profile, future work could focus on potential pharmacological interventions, as well as cognitive remediation.

Additional information

AH is supported by the Foundation for Polish Science (FNP). The funding source had no role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the article for publication. This study was not preregistered.

Footnotes

Declaration of competing interest

The authors declare no conflict of interest.

Data availability

Data, code and full report are available on OSF (https://osf.io/zx9p7/?view_only=481c531076bb42339e6aefb573f3ba1b).

References

  1. Allen Kenneth J.D., Hooley Jill M., 2019. Negative Emotional Action Termination (NEAT): support for a cognitive mechanism underlying negative urgency in nonsuicidal self-injury. Behav. Ther. 50 (5), 924–937. [DOI] [PubMed] [Google Scholar]
  2. Anderson Craig A., Deuser William E., DeNeve Kristina M., 1995. Hot temperatures, hostile affect, hostile cognition, and arousal: tests of a general model of affective aggression. Personal. Soc. Psychol. Bull. 21 (5), 434–448. [Google Scholar]
  3. Bates Douglas, Mächler Martin, Bolker Benjamin M., Walker Steven C., 2015. Fitting linear mixed-effects models using lme4. J. Stat. Softw. 10.18637/jss.v067.i01. [DOI] [Google Scholar]
  4. Beach Victoria L., Gissandaner Tre D., Schmidt Adam T., 2021. The UPPS model of impulsivity and suicide: a systematic literature review. Arch. Suicide Res. March, 1–22. [DOI] [PubMed] [Google Scholar]
  5. Berg Joanna M., Latzman Robert D., Bliwise Nancy G., Lilienfeld Scott O., 2015. Parsing the heterogeneity of impulsivity: a meta-analytic review of the behavioral implications of the UPPS for psychopathology. Psychol. Assess. 27 (4), 1129–1146. [DOI] [PubMed] [Google Scholar]
  6. Billieux Joël, Heeren Alexandre, Rochat Lucien, Maurage Pierre, Bayard Sophie, Bet Romain, Besche-Richard Chrystel, et al. , 2021. Positive and negative urgency as a single coherent construct: evidence from a large-scale network analysis in clinical and non-clinical samples. J. Pers. 89 (6), 1252–1262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Brannan T, Martinez-Tica J, Yahr MD, 1991. Effect of yohimbine on brain monoamines: an in vivo study. J. Neural Transm. Park. Dis. Dement. Sect. 3 (2), 81–87. [DOI] [PubMed] [Google Scholar]
  8. Canale Natale, Rubaltelli Enrico, Calcagnì Antonio, Vieno Alessio, Giovannoni Marta, Devos Gaëtan, Billieux Joël, 2022. The effects of induced sadness, stress sensitivity, negative urgency, and gender in laboratory gambling. Int. Gambl. Stud. January, 1–24. [Google Scholar]
  9. Carver CS, Johnson SL, Joormann J, Kim Y, Nam JY, 2011. Serotonin transporter polymorphism interacts with childhood adversity to predict aspects of impulsivity. Psychol. Sci. 22 (5), 589–595. 10.1177/0956797611404085. [DOI] [PubMed] [Google Scholar]
  10. Carver Charles S., Johnson Sheri L., Timpano Kiara R., 2017. Toward a functional view of the P factor in psychopathology. Clin. Psychol. Sci. 10.1177/2167702617710037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Caswell Amy J., Bond Rod, Duka Theodora, Morgan Michael J., 2015. Further evidence of the heterogeneous nature of impulsivity. Personal. Individ. Differ. 76, 68–74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Clark Luke, Robbins Trevor W., Ersche Karen D., Sahakian Barbara J., 2006. Reflection impulsivity in current and former substance users. Biol. Psychiatry 60 (5), 515–522. [DOI] [PubMed] [Google Scholar]
  13. Cohen Jacob, 1988. Statistical Power Analysis for the Behavioral Sciences. 10.4324/9780203771587. [DOI] [Google Scholar]
  14. Cyders Melissa A., Smith Gregory T., 2008. Emotion-based dispositions to rash action: positive and negative urgency. Psychol.Bull. 134 (6), 807–828. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Cyders Melissa A., Smith Gregory T., Spillane Nichea S., Fischer Sarah, Annus Agnes M., Peterson Claire, 2007. Integration of impulsivity and positive mood to predict risky behavior: development and validation of a measure of positive urgency. Psychol. Assess. 19 (1), 107–118. [DOI] [PubMed] [Google Scholar]
  16. Cyders Melissa A., Zapolski Tamika C.B., Combs Jessica L., Settles Regan Fried, Fillmore Mark T., Smith Gregory T., 2010. Experimental effect of positive urgency on negative outcomes from risk taking and on increased alcohol consumption. Psychol.Addict.Behav. 24 (3), 367–375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Falk R Frank Miller, Nancy B, 1992. A Primer for Soft Modeling, 103 https://psycnet.apa.org/fulltext/1992-98610-000.pdf. [Google Scholar]
  18. Faul Franz, Erdfelder Edgar, Buchner Axel, Lang Albert-Georg, 2009. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav. Res. Methods 41 (4), 1149–1160. [DOI] [PubMed] [Google Scholar]
  19. Fischer Sarah, Smith Gregory T., Cyders Melissa A., 2008. Another look at impulsivity: a meta-analytic review comparing specific dispositions to rash action in their relationship to bulimic symptoms. Clin. Psychol. Rev. 28 (8), 1413–1425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Franken Ingmar H.A., van Strien Jan W., Nijs Ilse, Muris Peter, 2008. Impulsivity is associated with behavioral decision-making deficits. Psychiatry Res. 158 (2), 155–163. [DOI] [PubMed] [Google Scholar]
  21. Herman Aleksandra M., Critchley Hugo D., Duka Theodora, 2018. The role of emotions and physiological arousal in modulating impulsive behaviour. Biol. Psychol. 133 (March), 30–43. [DOI] [PubMed] [Google Scholar]
  22. Herman Aleksandra M., Critchley Hugo D., Duka Theodora, 2019a. The impact of yohimbine-induced arousal on facets of behavioural impulsivity. Psychopharmacology 236 (6), 1783–1795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Herman Aleksandra M., Critchley Hugo D., Duka Theodora, 2019b. Binge drinking is associated with attenuated frontal and parietal activation during successful response inhibition in fearful context. Eur. J. Neurosci. 50 (3), 2297–2310. [DOI] [PubMed] [Google Scholar]
  24. Johnson Sheri L., Tharp Jordan A., Peckham Andrew D., Sanchez Amy H., Carver Charles S., 2016. Positive urgency is related to difficulty inhibiting prepotent responses. Emotion 16 (5), 750–759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Johnson Sheri L., Haase Claudia M., Beermann Ursula, Sanchez Amy H., Tharp Jordan A., Lwi Sandy J., Casey James J., Nguyen Nguyen Khoi, 2017. Positive urgency and emotional reactivity: evidence for altered responding to positive stimuli. Emotion 17 (3), 442–449. [DOI] [PubMed] [Google Scholar]
  26. Kirby KN, Petry NM, Bickel WK, 1999. Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls. J. Exp. Psychol. Gen. 128 (1), 78–87. [DOI] [PubMed] [Google Scholar]
  27. Lynam Donald R., Whiteside Stephen P., Cyders Melisa A., 2006. The UPPS-P: Assessing Five Personality Pathways to Impulsive Behavior (Technical Report). Purdue University, West Lafayette. [Google Scholar]
  28. Madden Gregory J., Petry Nancy M., Johnson Patrick S., 2009. Pathological gamblers discount probabilistic rewards less steeply than matched controls. Exp. Clin. Psychopharmacol. 17 (5), 283–290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Malouff JM, Thorsteinsson EB, Schutte NS, 2005. The relationship between the five-factor model of personality and symptoms of clinical disorders: A meta-analysis. J. Psychopathol. Behav. Assess. 27, 101–114. 10.1007/s10862-005-5384-y. [DOI] [Google Scholar]
  30. Manasse Stephanie M., Crochiere Rebecca J., Dallal Diane H., Lieber Edward W., Schumacher Leah M., Crosby Ross D., Butryn Meghan L., Forman Evan M., 2018. A multimodal investigation of impulsivity as a moderator of the relation between momentary elevations in negative internal states and subsequent dietary lapses. Appetite 127 (August), 52–58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Mather Mara, Clewett David, Sakaki Michiko, Harley Carolyn W., 2016. Norepinephrine ignites local hotspots of neuronal excitation: how arousal amplifies selectivity in perception and memory. Behav.Brain Sci. 39 (January), e200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Norbury Agnes, Manohar Sanjay, Rogers Robert D., Husain Masud., 2013. Dopamine modulates risk-taking as a function of baseline sensation-seeking trait. J. Neurosci. 33 (32), 12982–12986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Owens Max M., Amlung Michael T., Stojek Monika, MacKillop James., 2018. Negative urgency moderates reactivity to laboratory stress inductions. J. Abnorm. Psychol. 127 (4), 385–393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Pearlstein Jennifer G., Johnson Sheri L., Modavi Kiana, Peckham Andrew D., Carver Charles S., 2019. Neurocognitive mechanisms of emotion-related impulsivity: the role of arousal. Psychophysiology 56 (2), e13293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Pearlstein Jennifer G., Johnson Sheri L., Madole James W., Modavi Kiana., 2022. Emotion-related impulsivity: testing a model of arousal effects on cognitive control. BrainNeurosci.Adv. 6 (January), 23982128221079572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Rey A, 1964. L’examen Clinique En Psychologie, 2nd ed. Presses universitaires de France, Paris. [Google Scholar]
  37. Robertson Chelsea L., Ishibashi Kenji, Mandelkern Mark A., Brown Amira K., Ghahremani Dara G., Sabb Fred, Bilder Robert, Cannon Tyrone, Borg Jacqueline, London Edythe D., 2015. Striatal D1- and D2-type dopamine receptors are linked to motor response inhibition in human subjects. J. Neurosci. 35 (15), 5990–5997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Roxburgh Ariel D., White David J., Cornwell Brian R., 2022. Negative urgency is related to impaired response inhibition during threatening conditions. Acta Psychol. 228 (August), 103648. [DOI] [PubMed] [Google Scholar]
  39. Sperry Sarah H., Lynam Donald R., Kwapil Thomas R., 2018. The convergence and divergence of impulsivity facets in daily life. J. Pers. 86 (5), 841–852. [DOI] [PubMed] [Google Scholar]
  40. VanderVeen J Davis Plawecki, Martin H, Millward James B., Hays James, Kareken David A., O’Connor Sean, Cyders Melissa A., 2016. Negative urgency, mood induction, and alcohol seeking behaviors. Drug Alcohol Depend. 165 (August), 151–158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Whiteside Stephen P., Lynam Donald R., 2001. The five factor model and impulsivity: using a structural model of personality to understand impulsivity. Personal. Individ. Differ. 30 (4), 669–689. [Google Scholar]
  42. Wise Richard J., Phung Alissa L., Labuschagne Izelle, Stout Julie C., 2015. Differential effects of social stress on laboratory-based decision-making are related to both impulsive personality traits and gender. Cognit. Emot. 29 (8), 1475–1485. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Data, code and full report are available on OSF (https://osf.io/zx9p7/?view_only=481c531076bb42339e6aefb573f3ba1b).

RESOURCES